Technology | October 30, 2008

CadOne Mammography Solution Targets OEMs

CadOne is Three Palm Software’s mammography computer-aided detection (CAD) solution offered to original equipment manufacturers (OEM) for integration into their product suites.

For the end-user, this CAD product offers the following features:
- CadOne operates seamlessly within the mammography workflow
- CadOne offers three different operating points
- CadOne does not limit the number of views per study
- CAD reports include mass density and calcification cluster marks
- CAD reports optionally include information that can be utilized to enhance mammogram viewing capability: breast border; pectoral muscle border; nipple position; outlines of mass densities and calcifications
- Single CAD device can support multiple types of FFDM systems
- CAD reports are encoded as Mammography SR and can be displayed on standard Mammography workstations
- Throughput of 120 – 690 cases per hour on a dual-core CPU for a standard 4-view study with image resolutions ranging from 25µm to 100µm.

Most important technical specifications:
For a Healthcare Enterprise integrating Mammography CAD into its IT environment, CadOne offers the following features: DICOM MG (For Processing) source data; DICOM SR output; connectivity; dual-core 2.3GHz or higher; 1GB or more RAM.

For an OEM vendor adding CAD to its Mammography portfolio, CadOne offers the following features: software-only install; runs on a range of Windows platforms (including XP, Windows Server, Windows Vista); runs as a service and does not require any end-user interaction; can co-exist on a computer system with other services and end-user applications; stand-alone service tool; custom integration options (such as source data via private path; output in custom formats).

Related Content

Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
Enlitic Closes Series B Funding for Artificial Intelligence Solutions for Radiologists
News | Artificial Intelligence | April 08, 2019
Radiology artificial intelligence (AI) company Enlitic announced the close of its $15 million Series B financing round...
iCAD Highlighting ProFound AI for Tomosynthesis at 2019 SBI Annual Symposium
News | Computer-Aided Detection Software | April 04, 2019
iCAD announced it will present its latest artificial intelligence (AI) software solution for digital breast...
A smart algorithm developed by iCAD

A smart algorithm developed by iCAD outlines and scores a suspicious lesion seen in an image created using digital breast tomography. Displayed is the probability calculated by the algorithm that the outlined area includes a cancerous lesion. Image courtesy of Emily Conant, M.D.

Feature | Artificial Intelligence | April 03, 2019 | Greg Freiherr
  Editor's Note: This article was updated following the SBI symposium.  
Siemens Healthineers Debuts AI-Rad Companion Chest CT
News | Artificial Intelligence | January 25, 2019
Siemens Healthineers presented its first intelligent software assistant for radiology, the AI-Rad Companion Chest CT,...
Telerad Tech Launches MammoAssist AI Software
Technology | Computer-Aided Detection Software | January 25, 2019
Telerad Tech recently announced the launch of MammoAssist, a new artificial intelligence (AI) product to analyze and...
Videos | Artificial Intelligence | December 13, 2018
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors showing...
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...